A new study mentioned in this week’s Nature caught my eye–
“Molly Schmid and Helen Liu looked at the 3,790 jobs that were open in July at the top five revenue-generating drug companies (Pfizer, GlaxoSmithKline, Sanofi- Aventis, Merck and Johnson & Johnson) and the top four biotechnology firms (Amgen, Genentech, Biogen IDEC and Genzyme). The results may surprise lifescience researchers.
Roughly 17% of the jobs were for positions in research and development (R&D); the rest were for jobs related to the business side of the companies. Of these, 7% were in manufacturing, 24% were in administration (including duties such as information technology, finance and legal services), 25% were regulatory jobs (such as quality control, technical writing and statistical analysis), and 27% were in sales and marketing.”
This doesn’t surprise me in the least. Once again, we are producing PhD students for a job market that has changed, and academia is slow on the uptake.